# UAT and Test Evidence — Business-Reasoning Readout

## Evidence boundary

This readout explains why the critical ContinuumOS prototype checks matter. It summarises local automated tests, browser walkthroughs and controlled synthetic scenario runs. It is not external user acceptance testing, clinical validation, production approval or evidence of real operational performance.

The recorded release decision was **Conditional Go for structured synthetic review and synthetic workflow evaluation only**.

## Critical business and safety checks

| Critical scenario | Risk if it fails | Decision or control validated | Recorded evidence and result | Limitation |
|---|---|---|---|---|
| Authorised launch and protected-context failure | Patient or episode information could appear without established demonstration context | Protected context remains hidden when launch/access is unavailable | Launch controller/story tests and browser walkthrough passed | Simulated launch only; no production OAuth, identity provider or access certification |
| Patient and encounter linkage | Evidence could attach to the wrong episode or progress silently | Uncertain linkage is quarantined and requires the accountable human resolver | Workflow-rule and exception tests passed; missing encounter and patient-match paths remained blocked | One synthetic tracer; no enterprise MPI or real matching-performance evidence |
| Current report acknowledgement | “Result available” could be mistaken for clinical review | Only the assigned Clinic physician can acknowledge the current complete version | Review-controller, story and browser checks passed; `EVT-10` appeared only after valid human action | No clinical judgement or source-system acknowledgement write-back was tested |
| Stale or amended report handling | A previous acknowledgement or downstream content could be reused against a superseded version | Current version is required; amendment reopens review and preserves prior history | Stale-version and amended-report tests passed | Fixture-specific rule; not a universal FHIR or organisational policy |
| Human follow-up direction | The system could preselect or infer a clinical pathway | Direction begins unselected and requires Clinic physician evidence | Direction controller/story tests passed; no-selection and wrong-role attempts stayed blocked | No clinical appropriateness or real physician usability validation |
| Referral package and explicit route | Incomplete or unapproved content could be sent, or sending could be mistaken for acceptance | Referral Coordinator routing requires complete evidence and applicable clinical approval | Referral controller/story tests passed; incomplete, duplicate and failed-send paths remained blocked | No real referral network, send or receiving integration |
| Receiving-team response | A coordinator could appear to decide for the receiving team, or acceptance could be inferred | Named receiving authority, recording attribution and accept/reject evidence remain distinct | Receiving-response controller/story tests passed | Represented receiving roles and synthetic evidence only |
| Next-step confirmation and scoped closure | Acceptance or communication delivery could be mistaken for confirmed care or complete treatment | Confirmation requires complete human-owned evidence; closure is a separate action | Confirmation/closure tests and browser interaction passed | “Episode Completed” covers diagnostic-closure scope only, not all care |
| Exception resolution and safe return | Recovery could recreate the original action, duplicate progression or bypass authority | Accountable role, verified evidence and manual return to the last verified state are required | Exception controller/story tests passed; wrong-role and duplicate recovery remained blocked | No live reconciliation, retry service or external-system recovery |
| AI current, stale, corrected and unavailable outputs | Unsupported or stale content could influence workflow, or AI failure could block work | Human disposition, correction rationale, source/version controls and manual fallback | Four recorded AI evaluation scenarios passed; `EVT-20` created no canonical state change | Pre-written fixtures; not model accuracy, fairness, reliability or clinical-safety evidence |
| Audit-trace presentation | Material actions could be unattributed or history could appear editable | Chronological read-only representative events retain actor, source/version and outcome | Audit controller/story checks passed | Static representative history; not live audit ingestion, immutable storage or monitoring |
| Accessibility and interaction states | A keyboard or assistive-technology user could miss task purpose, feedback or safe recovery | Native controls, focus behaviour, text-plus-symbol status and responsive layouts | Automated/static checks, browser checks and Product Owner-reported physical keyboard/assistive-technology retest passed | Not independent accessibility certification or a full screen-reader audit |

## Evidence chain

| Level | Primary evidence | What it establishes |
|---|---|---|
| Requirement and acceptance baseline | [Requirements register](../Sprint_5_Clickable_Prototype/consolidated_requirements_register.csv), [acceptance criteria](../Sprint_5_Clickable_Prototype/acceptance_criteria_catalogue.md) | Intended behaviour and boundaries |
| Traceability | [Requirements traceability matrix](../Sprint_5_Clickable_Prototype/requirements_traceability_matrix.csv) | Requirement → story → acceptance criterion → test/defect/sign-off references |
| Automated and browser execution | [Test execution evidence](../Sprint_6_Prototype_Build_Testing_and_Controlled_Release/test_execution_evidence.csv) | Recorded local checks and observed outcomes |
| UAT-style decision | [UAT readiness and sign-off tracker](../Sprint_6_Prototype_Build_Testing_and_Controlled_Release/uat_readiness_and_signoff_tracker.csv) | One authorised-role synthetic walkthrough and bounded Product Owner disposition |
| Defect and retest | [Defect log](../Sprint_6_Prototype_Build_Testing_and_Controlled_Release/defect_log_and_triage_matrix.csv) | Observed gaps, impact, correction and retest |
| AI evaluation | [AI evaluation results](../Sprint_6_Prototype_Build_Testing_and_Controlled_Release/ai_evaluation_results.csv) | Fixture-level source, authority, stale-output and fallback controls |
| Synthetic pilot | [Synthetic pilot method and run log](synthetic_pilot_dataset_and_method.md), [pilot summary](pilot_result_summary.csv) | 20 controlled runs of one tracer, not 20 episodes |
| Release boundary | [Go/No-Go and rollback criteria](../Sprint_6_Prototype_Build_Testing_and_Controlled_Release/go_no_go_rollback_and_pilot_entry_criteria.md) | Conditional Go for synthetic review only |

## Recorded result

- Final recorded deterministic suite: 85/85 Node tests passed.
- Synthetic scenario runs: 20/20 passed for one approved tracer.
- Browser-observed action elapsed times: 0.311–0.748 seconds for four scripted actions.
- Internal Product Owner findings: six bounded presentation findings were corrected and retested.
- External structured reviews: none; the planned work was explicitly waived and the reviewer register remains empty.

The elapsed times are local scripted interaction feedback, not human task time, turnaround time, SLA performance or productivity improvement.

## What remains unvalidated

- real clinical and operational workflow fit;
- external user comprehension and adoption;
- production identity, access, security and resilience;
- live interoperability and data quality;
- model performance, fairness and supplier assurance;
- real operating thresholds and KPI baselines;
- production accessibility conformance;
- clinical outcomes, safety incidence or economic benefit.
